A Phase 1 Safety and Dose Finding Study of 131I -TLX101 Plus Standard of Care in Patients with Newly Diagnosed Glioblastoma

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515466-13-00

Acronym

131I-TLX-101-002

Enrollment

Registered

2024-09-08

Start date

2023-06-28

Completion date

Unknown

Last updated

2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma multiforme (GBM)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026